Gold nanoparticles (AuNPs), which have been widely used for the delivery of photosensitizers for photodynamic therapy (PDT) of cancer, can be dispersed in aqueous solutions, improving the delivery of the hydrophobic photosensitizer into the body. Furthermore, the large surface of AuNPs can be functionalized with a variety of ligands, including proteins, nucleic acids and carbohydrates, that allow selective targeting to cancer tissue. In this study, gold nanoparticles were functionalized with a mixed monolayer of a zinc phthalocyanine and a lactose derivative.
Introduction
Carbohydrates are present on the surface of human cells in the form of glycans; oligosaccharides either bound to proteins or lipids on the surface of the cells, or free within the tissue. [1, 2] The surface of the cells also presents lectins, carbohydrate-binding proteins that recognize glycans in a specific manner via their carbohydrate-recognizing domain (CRD). [1] [2] [3] Glycans and lectins are involved in many important roles in an organism, [4] including embryonic development, cell growth, differentiation and adhesion, apoptosis, cell signaling, cell-cell recognition, interactions between cells and the extracellular matrix and the regulation of hostpathogen interactions, amongst others. [1] [2] [3] 5] It is known that changes in the phenotypic distribution of glycans and lectins is linked with cancer. [3, [5] [6] [7] The changes in the expression of glycans and lectins can be related to the under-or over-expression of the enzymes responsible for their biosynthesis, glycosyltransferases and glycosidases, as well as their localization within the Golgi apparatus, to the expression of oncofetal antigens only present in embryonic cells and cancer cells, but not in healthy adult tissue, or to changes in the carbohydrate structure. [2, 3, 6, 8] Therefore, the aberrant glycosylation patterns in cancer cells can be used for targeted cancer therapy. Such targeting could be performed using carbohydrates to target endogenous lectins,
i.e., direct lectin-targeting or glycotargeting, or using lectins to target glycoconjugates expressed on the surface of the cancer cells, i.e., reverse lectin-targeting. [9] [10] [11] Targeted cancer therapies have been reported using both direct [12] [13] [14] [15] [16] [17] [18] [19] and reverse [20] [21] [22] [23] [24] [25] [26] lectin-targeting.
Galectins are β-galactoside-binding lectins whose over-or under-expression has been linked with cancer. [27] [28] [29] [30] Fifteen different mammalian galectins have been identified to date. [31] [32] [33] Among them, overexpression of galectin-1 has been linked with breast cancer. [31, 32, [34] [35] [36] [37] [38] Galectin-1 has been correlated with an increased tumor aggressiveness and poor prognosis, due to its ability to promote cell adhesion, leading to metastasis. [31, 32, 39] It has been shown that the suppression of galectin-1 can prevent both tumor growth and metastasis. [34, 36] Therefore, galectin-1 would be an ideal candidate for targeted cancer treatment, such as photodynamic therapy (PDT).
Here, we present the use of a carbohydrate, lactose, to stabilize AuNPs in aqueous solutions and to specifically target the galectin-1 receptor overexpressed on the surface of breast cancer cells.
Following previous reports by our group, [20, 40, 41] gold nanoparticles were synthesized and functionalized with a mixed monolayer of lactose and a zinc phthalocyanine (Pc)
photosensitizer. Two Pcs were explored, differing in the length of the carbon chain that connects the Pc to the gold core, consisting of either 3 or 11 carbon atoms. [42] The lactose disaccharide is made up of glucose and galactose residues. Galectin-1 has been shown to recognize and bind to both sugar units. [27] Therefore, lactose is potentially an ideal candidate as a ligand for targeted PDT.
A known lactose-containing thiol derivative, [43] Figure 1a , was chosen to evaluate the potential targeting towards the galectin-1 receptor on breast cancer cells. Importantly, the lactose ligand was shown to stabilize the zinc phthalocyanine-functionalized gold nanoparticles (AuNPs) in aqueous solutions. The phthalocyanines used for this study were two octa-alkyl substituted zinc (II) phthalocyanines, differing in the length of the carbon chain connecting the macrocycle to the disulfide bond, either three carbon atoms (C3Pc) or eleven carbon atoms (C11Pc). [42] Schematic representations of the synthesized gold nanoparticles functionalized with a mixed monolayer of lactose and either C3Pc (lactose-C3Pc-AuNPs) or C11Pc (lactose-C11Pc-AuNPs) are shown in Figure 1b and Figure 1c , respectively.
Figure 1. (a)
Structure of the thiolated lactose ligand. [43] Schematic representation of the (b)
lactose-C3Pc-AuNPs and (c) lactose-C11Pc-AuNPs.
Experimental

Materials and methods
All reagents were of analytical grade, used as received and purchased from Sigma-Aldrich (UK) UV-vis spectra were recorded using a Hitachi U-3010 spectrophotometer at room temperature using quartz cuvettes with a 1 cm path length. Fluorescence excitation and emission spectra were obtained using a Hitachi F-4500 fluorescence spectrometer in quartz cuvettes with a 1 cm path length. For the plate assays, absorbance and fluorescence measurements were performed using a CLARIOstar® (BMG Labtech) microplate reader at room temperature. Transmission electron microscopy (TEM) images were obtained using a JEOL JEM-2010 Electron Microscope operating at 200 kV. Centrifugation of nanoparticle samples was performed using a Beckman
Coulter Allegra™ X-22R centrifuge. Centrifugation of biological samples was performed using an Eppendorf 5810R centrifuge. Confocal microscopy was performed using a Carl Zeiss LSM 510
META confocal laser scanning microscope.
Phosphate buffered saline (PBS) was prepared by dissolving 10 PBS tablets in water (1 L 
Synthesis of lactose-Pc-AuNPs
Two zinc phthalocyanines (Pc) composed of either a three carbon-atom chain (C3Pc) or an eleven carbon-atom chain (C11Pc) connecting the macrocycle to the sulfur were prepared as previously reported. [44, 45] Gold nanoparticles (ca. 3-5 nm; AuNPs) were synthesized by sodium borohydride (NaBH 4 ) reduction and functionalized with a mixed monolayer of a lactose derivative [43] together with either C11Pc or C3Pc. To purify the mixture, excess dry THF (6 mL) was added rapidly and under vigorous stirring, followed by centrifugation in Eppendorf tubes (1.5 mL) at 1,300 rpm for 2 min at 4 °C. The supernatant was collected and the brown pellet containing AuNPs functionalized only with lactose was discarded. The solvent mixture in the supernatant was evaporated by rotary evaporation under reduced pressure at 70 °C. For further purification, another aliquot of THF (5.4 mL) was added, followed by the same centrifugation and evaporation steps as explained previously. Once all the THF had been evaporated, MES buffer (3 mL) was added and the solubilization was assisted using an ultrasonic bath. The solution was centrifuged in Eppendorf tubes (1.5 mL) at 14,000 rpm for 30 min at 4 °C. The pellet containing free Pc and AuNPs functionalized only with Pc, and thus not soluble in an aqueous solution, was discarded. The supernatant containing the lactose-Pc-AuNPs was collected and filtered through a Millex GP syringe driven filter unit (0.22 μm). The synthesized lactose-Pc-AuNPs were characterized using UV-vis spectroscopy, between 300-800 nm, and using TEM. A droplet of the functionalized AuNPs (20 μL) in MES buffer was placed onto a holey carbon film 300 mesh copper grid and left for 2 min to allow the nanoparticles to sediment onto the grid. Excess MES buffer was then removed by gently poking the side of the grid with filter paper. The grid was left to dry completely before imaging.
Measurement of singlet oxygen production
The lactose-Pc-AuNPs (511 μL) in MES buffer were placed in a 1.5 mL quartz cuvette together with ABMA (1 μL in methanol; 1 μM) and a magnetic stirrer bar. Oxygen was bubbled through the solution and the quartz cuvette was stoppered. The fluorescence emission spectrum of the initial solution was recorded, using an excitation wavelength of 380 nm, between 390-600 nm.
The sample was then irradiated at 633 nm using a 10 mW HeNe laser for 40 min with continuous stirring. The laser was placed 50 cm away from the cuvette. The fluorescence emission spectrum of the sample was recorded every 5 min. and added to the gold salt plus Pc-sPEG solutions rapidly and under vigorous stirring. The reaction was stirred overnight (ca. 17 h) at room temperature in the dark at moderate speed.
Synthesis of control sPEG-Pc-AuNPs
The resulting solution was purified following the method described above for the synthesis of lactose-Pc-AuNPs. 
In vitro cell work
Results and discussion
The synthesized lactose-C3Pc-AuNPs and lactose-C11Pc-AuNPs were characterized via TEM and UV-vis spectroscopy, as shown in Figure 2 . Confirmation of the functionalization of the AuNPs with C3Pc or C11Pc was obtained by UV-vis spectroscopy (Figure 2e) , which clearly shows the characteristic band of these phthalocyanines at ca. 698 nm. [20, 40] Confirmation of the functionalization with lactose was obtained due to the facile dispersibility of the AuNPs in aqueous systems, which would otherwise be insoluble due to the hydrophobicity of the C3Pc and C11Pc. The aqueous stabilization of AuNPs with a carbohydrate, which is additionally used as a targeting agent for PDT, has not been reported previously. The lactose-C3Pc-AuNPs were found to be 3.10 ± 1.32 nm in size and the lactose-C11Pc-AuNPs were found to be 2.37 ± 1.65 nm, as analyzed by TEM (Figure 2a-d) . The nanoparticles were evaluated for production of singlet oxygen ( 1 O 2 ), using the 1 O 2 probe 9,10-anthracenediyl-bis (methylene) dimalonic acid (ABMA). Both nanoparticle systems were shown to generate 1 O 2 , as shown in Figure 2f , with the lactose-C3Pc-AuNPs producing more 1 O 2 than the lactose-C11Pc-AuNPs, which is thought to be due to surface enhanced effects with the C3Pc molecule. [42] Additionally, control AuNPs, used to evaluate the targeting ability of lactose within the lactoseC3Pc-AuNPs, were synthesized. For the control AuNPs, the lactose ligand was substituted for a polyethylene glycol ligand of a short length (sPEG), thiol-dPEG® 4 -acid shown in Figure 3a, resembling the length of the lactose ligand. The purpose of the sPEG ligand was to facilitate the solubility of the Pc-sPEG-AuNPs in aqueous solutions. Schematic representations of the synthesized gold nanoparticles functionalized with a mixed monolayer of sPEG and either C3Pc
(C3Pc-sPEG-AuNPs) or C11Pc (C11Pc-sPEG-AuNPs) can be seen in Figure 3b and 3c, respectively, and the UV-vis characterisation of the C3Pc-sPEG-AuNPs and C11Pc-sPEG-AuNPs, in Figure 3d and 3e. Two breast adenocarcinoma cell lines were explored, SK-BR-3 and MDA-MB-231 cells. The levels of galectin-1 on the surface of each cell line were estimated using an enzyme linked immunosorbent assay (ELISA). For this purpose, the cells were fixed and treated with antigalectin-1 antibody. [46] The ELISA showed higher levels of galectin-1 in MDA-MB-231 cells as compared to SK-BR-3 cells (Figure 4a) . Therefore, the MDA-MB-231 cell line was expected to be the better target for the lactose-C3Pc-AuNPs or lactose-C11Pc-AuNPs than the SK-BR-3 cell line.
The potential targeting ability of lactose-C3Pc-AuNPs and lactose-C11Pc-AuNPs towards the galectin-1 receptor was then investigated in each cell line using an ELISA. To evaluate the targeting by lactose, the cells were treated with either lactose-C3Pc-AuNPs or lactose-C11Pc- It has been reported that the glucose transporter 1 also binds galactose, [18] and thus it could be a potential targeting receptor recognised by the lactose-Pc-AuNPs. Glucose transporter 1 (GLUT1) has been reported to be overexpressed on breast cancer cells. [48] [49] [50] [51] [52] [53] With consideration that only the lactose-C3Pc-AuNPs induced selective targeting of the galectin-1 receptor, and that these nanoparticle conjugates produced more 1 O 2 than the lactose-C11Pc-AuNPs (Figure 2) , the lactose-C3Pc-AuNPs were studied in vitro using both MDA-MB-231 and SK-BR-3 cells. The cells were incubated with either lactose-C3Pc-AuNPs or the control C3Pc-sPEGAuNPs for 24 hours, in order to maximise cell death, washed to remove all the non-internalized nanoparticles and irradiated with a 633 nm HeNe laser for 6 minutes. The cells were then subjected to CellTiter-Blue® cell viability assays to assess the PDT effect. Figure 5a shows the PDT effect in MDA-MB-231 cells. It can be seen that there is limited dark toxicity prior to irradiation with the laser. Additionally, post-PDT, the cell viability is reduced for samples treated with both lactose-C3Pc-AuNPs and C3Pc-sPEG-AuNPs. However, though there is an indication that the lactose-C3Pc-AuNPs could induce more cytotoxicity, with a lower cell viability post PDT, the levels of cell death are similar for both the lactose-C3Pc-AuNPs and the C3Pc-sPEG-AuNPs.
This suggests that the potential targeting between lactose and galectin-1 does not lead to a great increase in cytotoxicity post-PDT. For the SK-BR-3 cells, both lactose-C3Pc-AuNPs and C3Pc-sPEG-AuNPs induce similar levels of cell death following irradiation, leading to up to 95 % cell death (Figure 5b) . However, a clear advantage of using the lactose-C3Pc-AuNPs is highlighted by the significantly reduced dark toxicity as compared to the C3Pc-sPEG-AuNPs.
Non-cancerous mammary epithelial cells, MCF-10A cells, were also subjected to PDT via lactoseC3Pc-AuNPs and C3Pc-sPEG-AuNPs. As it can be seen in Initial cell viability studies with various concentrations of C11Pc within the AuNPs were performed, to evaluate the optimal concentration to be used for PDT. For this purpose, only SK-BR-3 cells were incubated with the lactose-C11Pc-AuNPs for 24 h and irradiated with a 633 nm HeNe laser for 6 minutes. Figure 8 clearly shows that the optimal concentration for these type of nanoparticles is 0.25 μM, as it showed minimal dark toxicity while some cell kill could be seen post PDT. Higher concentrations of the C11Pc (0.5 and 0.7 μM) led to cytotoxicity prior to cell irradiation so these concentrations were not used for PDT treatment. A study of concentrations of C11Pc with the lactose-C11Pc-AuNPs and C11Pc-sPEG-AuNPs (< 0.2 μM) did not achieve any cell death post PDT. These results are in contrast with the results seen for lower concentrations of the lactose-C3Pc-AuNPs and C3Pc-sPEG-AuNPs (see Figure 6 ).
Overall, the results reported here show that the lactose-C3Pc-AuNPs perform better than the lactose-C11Pc-AuNPs with both types of breast cancer cells studied.
Conclusions
In summary, we have shown that phthalocyanine functionalized gold nanoparticles can be stabilized and dispersed in aqueous solutions using a lactose derivative. These lactose- This study shows that lactose can be successfully used to target breast cancer cells. The use of a carbohydrate as a targeting agent has several advantages over other biomolecules such as antibodies. Cancer cells can become resistant to antibodies due to genetic mutations, leading to innate or acquired resistance towards the treatment, as seen for the use of Herceptin to treat HER2 positive breast cancers. [54, 55] Additionally, the present study has shown enhanced cell kill compared to previous work where other carbohydrates have been used for selective cancer targeting. [13, 15] More importantly, we have successfully increased levels of cell death with lower irradiation periods and radiation doses (29 mW/cm 2 ; 10.5 J/cm 2 for 6 minutes) to those reported previously (50 mW/cm 2 ; 90 J/cm 2 for 30 minutes). [13] In conclusion, the results reported show that the use of lactose to stabilize the hydrophobic phthalocyanine photosensitizer on the gold nanoparticles in aqueous solutions has clear advantages for targeted photodynamic therapy and suggests that other carbohydrates should be investigated for optimal targeting of ligands on cancer cells.
